HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

β-elemene sensitizes hepatocellular carcinoma cells to oxaliplatin by preventing oxaliplatin-induced degradation of copper transporter 1.

Abstract
β-elemene, a Curcuma wenyujin plant extract, has been used widely as a tumor adjuvant therapeutic agent. However, how to obtain optimum therapeutic effects by combining this compound with other agents remain unclear. In this study, we found that β-elemene, which alone had little effect on hepatocellular carcinoma (HCC) cell proliferation, exerted a synergistic anti-proliferative effect in HCC cells when dosed in combination with oxaliplatin, which increased the amounts of platinum accumulation and platinum-DNA adduct significantly and augmented the oxaliplatin-induced apoptosis. Western blot and laser scanning confocal microscopy studies indicated that β-elemene enhanced the sensitivity of HCC cells to oxaliplatin by upregulating copper transporter 1 (CTR1), a major controller of intracellular platinum accumulation. In an orthotopic transplantation HCC model in nude mice, HCC tumor growth was inhibited significantly by oxaliplatin combined with β-elemene, as compared with oxaliplatin alone. Notably, CTR1 protein expression in xenograft HCC was upregulated in mice who received β-elemene treatment. Taken together, our findings show that β-elemene can block the reduction of CTR1 resulting from oxaliplatin treatment, and therefore has a synergistic anti-HCC effect with oxaliplatin by enhancing cellular uptake of oxaliplatin. The synergistic effects of β-elemene and oxaliplatin deserve further evaluation in clinical settings.
AuthorsXiaoqiang Li, Zhenhai Lin, Bo Zhang, Lei Guo, Shuang Liu, Hui Li, Jubo Zhang, Qinghai Ye
JournalScientific reports (Sci Rep) Vol. 6 Pg. 21010 (Feb 12 2016) ISSN: 2045-2322 [Electronic] England
PMID26867799 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cation Transport Proteins
  • Copper Transporter 1
  • Neoplasm Proteins
  • Organoplatinum Compounds
  • SLC31A1 protein, human
  • Sesquiterpenes
  • beta-elemene
  • Oxaliplatin
Topics
  • Animals
  • Carcinoma, Hepatocellular (drug therapy, genetics, metabolism, pathology)
  • Cation Transport Proteins (genetics, metabolism)
  • Cell Line, Tumor
  • Copper Transporter 1
  • Humans
  • Liver Neoplasms (drug therapy, genetics, metabolism, pathology)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Neoplasm Proteins (genetics, metabolism)
  • Organoplatinum Compounds (pharmacology)
  • Oxaliplatin
  • Proteolysis (drug effects)
  • Sesquiterpenes (pharmacology)
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: